Zydus Lifesciences Gets USFDA’s Tentative Nod For Generic Ibrutinib Tablets Used In Blood Cancer

Zydus Lifesciences Gets USFDA’s Tentative Nod For Generic Ibrutinib Tablets Used In Blood Cancer

The tentative approval granted by the US Food and Drug Administration (USFDA) is for Ibrutinib tablets of strengths 140 mg, 280 mg, and 420 mg, Zydus Lifesciences said in a statement.

PTIUpdated: Thursday, July 24, 2025, 03:42 PM IST
article-image
Zydus Lifesciences Ltd on Thursday said it has received tentative approval from the US health regulatory agency for its generic version of cancer treatment drug Ibrutinib tablets. | X @stockwatch_live

New Delhi: Zydus Lifesciences Ltd on Thursday said it has received tentative approval from the US health regulatory agency for its generic version of cancer treatment drug Ibrutinib tablets.

The Ibrutinib tablets will be produced at Zydus Lifesciences Ltd SEZ, Ahmedabad, it added.

The company said Ibrutinib is indicated for the treatment of adult patients with different types of blood cancers, Chronic lymphocytic leukaemia (CLL)/Small lymphocytic lymphoma (SLL), and Waldenstrom's macroglobulinemia (WM).

Citing IQVIA MAT May 2025, Zydus said Ibrutinib tablets had annual sales of USD 2148.9 million in the US.

(Except for the headline, this article has not been edited by FPJ's editorial team and is auto-generated from an agency feed.)

RECENT STORIES

DLF And Trident Realty's Mumbai Debut 'The Westpark' Sells Out Phase 1, Clocks ₹2,300 Crore In...

DLF And Trident Realty's Mumbai Debut 'The Westpark' Sells Out Phase 1, Clocks ₹2,300 Crore In...

Stock Market Crash: Sensex Falls 1.52% In 2 Days, Investors Lose ₹8.67 Lakh Crore In Market...

Stock Market Crash: Sensex Falls 1.52% In 2 Days, Investors Lose ₹8.67 Lakh Crore In Market...

Gold Slips ₹500 To ₹99,120 Per 10g In Delhi Amid Trade Deal Hopes, Fed Rate Cut Uncertainty

Gold Slips ₹500 To ₹99,120 Per 10g In Delhi Amid Trade Deal Hopes, Fed Rate Cut Uncertainty

UK Media Hails 'Bumper' Trade Deal With India As Post-Brexit Win

UK Media Hails 'Bumper' Trade Deal With India As Post-Brexit Win

Wipro Liquidates Hungarian Step-Down Subsidiary As Part Of Group Consolidation

Wipro Liquidates Hungarian Step-Down Subsidiary As Part Of Group Consolidation